- Home
- XNCR vs VSEC Comparison
XNCR vs VSEC Comparison
Compare XNCR & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- VSEC
- Stock Information
- Founded
- XNCR 1997
- VSEC 1959
- Country
- XNCR United States
- VSEC United States
- Employees
- XNCR N/A
- VSEC N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- VSEC Military/Government/Technical
- Sector
- XNCR Health Care
- VSEC Consumer Discretionary
- Exchange
- XNCR Nasdaq
- VSEC Nasdaq
- Market Cap
- XNCR 1.5B
- VSEC 1.6B
- IPO Year
- XNCR 2013
- VSEC N/A
- Fundamental
- Price
- XNCR $24.10
- VSEC $114.26
- Analyst Decision
- XNCR Strong Buy
- VSEC Strong Buy
- Analyst Count
- XNCR 8
- VSEC 6
- Target Price
- XNCR $35.50
- VSEC $116.83
- AVG Volume (30 Days)
- XNCR 569.4K
- VSEC 186.2K
- Earning Date
- XNCR 11-06-2024
- VSEC 11-06-2024
- Dividend Yield
- XNCR N/A
- VSEC 0.35%
- EPS Growth
- XNCR N/A
- VSEC N/A
- EPS
- XNCR N/A
- VSEC 0.82
- Revenue
- XNCR $85,164,000.00
- VSEC $1,016,436,000.00
- Revenue This Year
- XNCR N/A
- VSEC $25.86
- Revenue Next Year
- XNCR $86.53
- VSEC $19.02
- P/E Ratio
- XNCR N/A
- VSEC $57.21
- Revenue Growth
- XNCR N/A
- VSEC 27.51
- 52 Week Low
- XNCR $15.31
- VSEC $57.10
- 52 Week High
- XNCR $26.84
- VSEC $123.92
- Technical
- Relative Strength Index (RSI)
- XNCR 70.71
- VSEC 60.44
- Support Level
- XNCR $22.60
- VSEC $112.56
- Resistance Level
- XNCR $23.86
- VSEC $123.92
- Average True Range (ATR)
- XNCR 0.83
- VSEC 3.91
- MACD
- XNCR 0.05
- VSEC -0.80
- Stochastic Oscillator
- XNCR 96.85
- VSEC 55.89
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management and consulting services for land, sea and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. Majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business and general aviation operators.